FDA drug approvals
Every approval of a new drug, generic or biologic by the US Food and Drug Administration, newest first, under the company that holds the application today, from Drugs@FDA. 25,670 approvals on file, 13,159 held by companies on value.today.
Approvals, 2026
724
all applicants
50
New uses approved, 2026
196
efficacy supplements
Approvals, 2025
824
50 new molecules
FDA approvals in 2024
853 approvals, newest first.
| Approved | Drug | Held by | Kind |
|---|---|---|---|
| 2024-12-31 | TromethamineTromethamine · Solution · Injection · ANDA213116 | MILLA PHARMS | Generic drug (ANDA) |
| 2024-12-31 | GlycopyrrolateGlycopyrrolate · Solution · Oral · ANDA214847 | 🇮🇳 Aurobindo Pharma Limited | Generic drug (ANDA) |
| 2024-12-31 | Safinamide MesylateSafinamide Mesylate · Tablet · Oral · ANDA215978 | MSN | Generic drug (ANDA) |
| 2024-12-31 | MetronidazoleMetronidazole · Gel · Vaginal · ANDA216750 | SCIEGEN PHARMS | Generic drug (ANDA) |
| 2024-12-31 | DiazepamDiazepam · Injectable · Injection · ANDA217178 | LONG GROVE PHARMS | Generic drug (ANDA) |
| 2024-12-31 | Sumatriptan SuccinateSumatriptan Succinate · Tablet · Oral · ANDA219036 | VKT PHARMA | Generic drug (ANDA) |
| 2024-12-30 | Brimonidine Tartrate And Timolol MaleateBrimonidine Tartrate, Timolol Maleate · Solution/Drops · Ophthalmic · ANDA217288 | 🇺🇸 Amneal Pharmaceuticals, Inc. | Generic drug (ANDA) |
| 2024-12-27 | BumetanideBumetanide · Tablet · Oral · ANDA213942 | RUBICON RESEARCH | Generic drug (ANDA) |
| 2024-12-27 | Opdivo QvantigNivolumab, Hyaluronidase-Nvhy · Injectable · Subcutaneous · BLA761381 | 🇺🇸 Bristol-Myers Squibb Company | Biologic (BLA) |
| 2024-12-27 | Opdivo QvantigNivolumab, Hyaluronidase-Nvhy · Injectable · Injection · BLA761429 | 🇺🇸 Bristol-Myers Squibb Company | Biologic (BLA) |
| 2024-12-26 | DeutetrabenazineDeutetrabenazine · Tablet · Oral · ANDA215971 | 🇮🇳 Aurobindo Pharma Limited | Generic drug (ANDA) |
| 2024-12-26 | Prucalopride SuccinatePrucalopride Succinate · Tablet · Oral · ANDA218492 | NOVITIUM PHARMA | Generic drug (ANDA) |
| 2024-12-26 | CyclophosphamideCyclophosphamide · Injectable · Injection · ANDA218632 | HAINAN POLY | Generic drug (ANDA) |
| 2024-12-26 | TevimbraTislelizumab-Jsgr · Injectable · Intravenous · BLA761417 | BEIGENE | Biologic (BLA) |
| 2024-12-23 | LiraglutideLiraglutide · Solution · Subcutaneous · ANDA215503 | 🇬🇧 Hikma Pharmaceuticals PLC | Generic drug (ANDA) |
| 2024-12-23 | EntecavirEntecavir · Tablet · Oral · ANDA216857 | CONBA USA | Generic drug (ANDA) |
| 2024-12-23 | EdaravoneEdaravone · Solution · Intravenous · ANDA216902 | 🇨🇭 Sandoz Group AG | Generic drug (ANDA) |
| 2024-12-23 | PosaconazolePosaconazole · Solution · Intravenous · ANDA219057 | ASPIRO | Generic drug (ANDA) |
| 2024-12-23 | Xromipriority reviewHydroxyurea · Solution · Oral · NDA216593 | NOVA LABS LTD | New drug (NDA) |
| 2024-12-20 | Sildenafil CitrateSildenafil Citrate · Tablet · Oral · ANDA201156 | 🇮🇳 Jubilant Life Sciences | Generic drug (ANDA) |
| 2024-12-20 | Tetracaine HydrochlorideTetracaine Hydrochloride · Solution · Ophthalmic · ANDA217227 | SOMERSET THERAPS LLC | Generic drug (ANDA) |
| 2024-12-20 | Icosapent EthylIcosapent Ethyl · Capsule · Oral · ANDA218994 | 🇮🇳 Torrent Pharmaceuticals Limited | Generic drug (ANDA) |
| 2024-12-20 | Alhemonew moleculepriority reviewConcizumab-Mtci · Injectable · Subcutaneous · BLA761315 | 🇩🇰 Novo Nordisk A/S | Biologic (BLA) |
| 2024-12-20 | Alyftreknew moleculepriority reviewDeutivacaftor, Tezacaftor, Vanzacaftor Calcium · Tablet · Oral · NDA218730 | 🇺🇸 Vertex Pharmaceuticals Incorporated | New drug (NDA) |
| 2024-12-19 | Raltegravir PotassiumRaltegravir Potassium · Tablet · Oral · ANDA203540 | HETERO LABS LTD III | Generic drug (ANDA) |
| 2024-12-19 | Dabigatran Etexilate MesylateDabigatran Etexilate Mesylate · Capsule · Oral · ANDA207922 | BRECKENRIDGE | Generic drug (ANDA) |
| 2024-12-19 | PhytonadionePhytonadione · Tablet · Oral · ANDA212112 | 🇬🇧 Hikma Pharmaceuticals PLC | Generic drug (ANDA) |
| 2024-12-19 | Abacavir Sulfate And LamivudineAbacavir Sulfate, Lamivudine · Tablet · Oral · ANDA212663 | MACLEODS PHARMS | Generic drug (ANDA) |
| 2024-12-19 | Carbinoxamine MaleateCarbinoxamine Maleate · Tablet · Oral · ANDA215476 | LEADING | Generic drug (ANDA) |
| 2024-12-19 | CyclophosphamideCyclophosphamide · Injectable · Injection · ANDA218644 | EPIC PHARMA LLC | Generic drug (ANDA) |
| 2024-12-19 | Divalproex SodiumDivalproex Sodium · Capsule, Delayed Rel Pellets · Oral · ANDA218793 | ALEMBIC | Generic drug (ANDA) |
| 2024-12-19 | Tryngolza (Autoinjector)new moleculepriority reviewOlezarsen Sodium · Solution · Subcutaneous · NDA218614 | 🇺🇸 Ionis Pharmaceuticals, Inc. | New drug (NDA) |
| 2024-12-18 | PirfenidonePirfenidone · Capsule · Oral · ANDA212748 | MACLEODS PHARMS | Generic drug (ANDA) |
| 2024-12-18 | Olopatadine HydrochlorideOlopatadine Hydrochloride · Solution/Drops · Ophthalmic · ANDA215006 | SOMERSET | Generic drug (ANDA) |
| 2024-12-18 | Phenylephrine HydrochloridePhenylephrine Hydrochloride · Solution/Drops · Ophthalmic · ANDA218129 | 🇮🇳 Gland Pharma Limited | Generic drug (ANDA) |
| 2024-12-18 | Fondaparinux SodiumFondaparinux Sodium · Solution · Subcutaneous · ANDA218312 | BRIGHTGENE | Generic drug (ANDA) |
| 2024-12-18 | Ensacovenew moleculeEnsartinib Hydrochloride · Capsule · Oral · NDA218171 | XCOVERY | New drug (NDA) |
| 2024-12-17 | CefiximeCefixime · Tablet · Oral · ANDA206358 | 🇮🇳 FDC Limited | Generic drug (ANDA) |
| 2024-12-17 | ApixabanApixaban · Tablet · Oral · ANDA210156 | 🇮🇳 Torrent Pharmaceuticals Limited | Generic drug (ANDA) |
| 2024-12-17 | Methylene BlueMethylene Blue · Solution · Intravenous · ANDA216959 | 🇬🇧 Hikma Pharmaceuticals PLC | Generic drug (ANDA) |
| 2024-12-17 | Calcium Chloride 10%Calcium Chloride · Injectable · Injection · ANDA218133 | SOMERSET | Generic drug (ANDA) |
| 2024-12-17 | Lisdexamfetamine DimesylateLisdexamfetamine Dimesylate · Tablet, Chewable · Oral · ANDA218850 | SPECGX LLC | Generic drug (ANDA) |
| 2024-12-17 | Lidocaine And PrilocaineLidocaine, Prilocaine · Cream · Topical · ANDA219120 | 🇮🇳 Zydus Lifesciences Limited | Generic drug (ANDA) |
| 2024-12-17 | SteqeymaUstekinumab-Stba · Injectable · Subcutaneous, Injectable · Intravenous · BLA761338 | 🇰🇷 Celltrion, Inc. | Biologic (BLA) |
| 2024-12-16 | ApremilastApremilast · Tablet · Oral · ANDA211887 | MSN | Generic drug (ANDA) |
| 2024-12-16 | NitroglycerinNitroglycerin · Ointment · Intra-Anal · ANDA216452 | ENCUBE | Generic drug (ANDA) |
| 2024-12-16 | Methadone HydrochlorideMethadone Hydrochloride · Injectable · Injection · ANDA218252 | BRECKENRIDGE | Generic drug (ANDA) |
| 2024-12-16 | Tofacitinib CitrateTofacitinib Citrate · Tablet, Extended Release · Oral · ANDA218668 | DEXCEL | Generic drug (ANDA) |
| 2024-12-16 | Lisdexamfetamine DimesylateLisdexamfetamine Dimesylate · Tablet, Chewable · Oral · ANDA219258 | GRANULES | Generic drug (ANDA) |
| 2024-12-13 | Emtricitabine And Tenofovir Alafenamide FumarateEmtricitabine, Tenofovir Alafenamide Fumarate · Tablet · Oral · ANDA213926 | 🇮🇳 Lupin Limited | Generic drug (ANDA) |
Most approvals in 2024
Companies on value.today.
Source: US Food and Drug Administration, Drugs@FDA (openFDA) · as of Nov 13, 2026. Approvals follow the application to its current holder, so an acquired company's approvals appear under the buyer. Vaccines and blood products are approved by another FDA centre and are not listed. How it is counted